多様なプレイヤーがオープンイノベーションを 実現する場を目指して ―サイエンスパークの現場から―.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 123, doi. 10.1254/fpj.24001
- By:
- Publication type:
- Article
Works matching IS 00155691 AND DT 2024 AND VI 159 AND IP 2
Results: 11
1
2
敗血症性多臓器不全の分子機構.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 101, doi. 10.1254/fpj.23109
- By:
- Publication type:
- Article
3
特集：クスリのリスクを科学する：基礎から臨床，過去から未来へ.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 77, doi. 10.1254/fpj.23102
- By:
- Publication type:
- Article
4
抗がん薬の心毒性リスク評価と今後の展望.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 83, doi. 10.1254/fpj.23094
- By:
- Publication type:
- Article
5
多価不飽和脂肪酸および FABP に着目した 精神疾患の病態解明.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 118, doi. 10.1254/fpj.23093
- By:
- Publication type:
- Article
6
薬理遺伝学検査に基づく重症薬疹発症リスクの予測.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 90, doi. 10.1254/fpj.23092
- By:
- Publication type:
- Article
7
薬害スモンの発症メカニズムの完全解明に向けて.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 78, doi. 10.1254/fpj.23085
- By:
- Publication type:
- Article
8
臨床薬理学的アプローチで克服する ハイリスク薬のマネジメント.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 96, doi. 10.1254/fpj.23082
- By:
- Publication type:
- Article
9
骨格筋に着目した敗血症病態生理学の 解明と創薬への応用.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 112, doi. 10.1254/fpj.23040
- By:
- Publication type:
- Article
10
特集：敗血症性多臓器不全の病態生理学的解明と創薬基盤形成.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 100, doi. 10.1254/fpj.23031
- By:
- Publication type:
- Article
11
血漿タンパク質 HRG は敗血症防止と 生体恒常性維持に働く重要な因子である.
- Published in:
- Folia Pharmacologica Japonica, 2024, v. 159, n. 2, p. 107, doi. 10.1254/fpj.23027
- By:
- Publication type:
- Article